Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals --Conference call to be held at 4:30 p.m. Eastern Time today-- HAMPTON, N.J., and NEW HAVEN, …
http://www.fool.com/investing/general/2016/10/17/is-this-ris…